Search

Your search keyword '"Park, Man-Seong"' showing total 433 results

Search Constraints

Start Over You searched for: Author "Park, Man-Seong" Remove constraint Author: "Park, Man-Seong"
433 results on '"Park, Man-Seong"'

Search Results

3. The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2

8. Age-Stratified Seroprevalence of Respiratory Syncytial Virus: Analysis using Prefusion F and G Protein Antibodies

12. Laboratory information management system for COVID-19 non-clinical efficacy trial data

15. Development and Validation of an Enzyme-Linked Immunosorbent Assay-Based Protocol for Evaluation of Respiratory Syncytial Virus Vaccines.

16. Omicron BA.2 breakthrough infection elicits CD8 + T cell responses recognizing the spike of later Omicron subvariants

17. Immune Cells Are Differentially Affected by SARS-CoV-2 Viral Loads in K18-hACE2 Mice

18. High‐resolution phylogeographical surveillance of Hantaan orthohantavirus using rapid amplicon‐based Flongle sequencing, Republic of Korea

20. A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein

24. 288. Analysis of serum antibody response as correlates of protection against SARS-CoV-2 infection and the effects of BA.4/5 bivalent booster vaccination

26. Mutational analysis of severe acute respiratory syndrome coronavirus 2 in immunocompromised patients with persistent viral detection using whole genome sequencing

27. Genome-informed investigation of the molecular evolution and genetic reassortment of severe fever with thrombocytopenia syndrome virus

28. A natural variation in the RNA polymerase of severe fever with thrombocytopenia syndrome virus enhances viral replication and in vivo virulence

30. A mouse xenograft long‐term replication yields a SARS‐CoV‐2 Delta mutant with increased lethality.

31. Exploring the Genetic Diversity and Molecular Evolution of Seoul and Hantaan Orthohantaviruses.

32. Omicron BA.2 breakthrough infection elicits CD8+ T cell responses recognizing the spike of later Omicron subvariants.

33. Prevention of hypoglycemia-induced neuronal death by minocycline

34. Corrigendum to “Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection” [J Infect 85 (2022) e69–e71]

38. Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection

39. In vitro and in vivo suppression of SARS‐CoV‐2 replication by a modified, short, cell‐penetrating peptide targeting the C‐terminal domain of the viral spike protein

41. Low Neutralizing Activities to the Omicron Subvariants BN.1 and XBB.1.5 of Sera From the Individuals Vaccinated With a BA.4/5-Containing Bivalent mRNA Vaccine

42. Comparison of the clinical and virological characteristics of SARS-CoV-2 Omicron BA.1/BA.2 and omicron BA.5 variants: A prospective cohort study

43. Establishment of multicenter COVID-19 therapeutics preclinical test system in Republic of Korea

44. Production of a Monoclonal Antibody to the Nucleocapsid Protein of SARS-CoV-2 and Its Application to ELISA-Based Detection Methods with Broad Specificity by Combined Use of Detector Antibodies

45. Comparison of secondary attack rate and viable virus shedding between patients with SARS‐CoV‐2 Delta and Omicron variants: A prospective cohort study

46. 305. Clinical scoring system to predict viable viral shedding in patients with COVID-19

48. Temporal Transcriptome Analysis of SARS-CoV-2-Infected Lung and Spleen in Human ACE2-Transgenic Mice

49. Comparison of the pathogenesis of SARS-CoV-2 infection in K18-hACE2 mouse and Syrian golden hamster models

50. Daily, self-test rapid antigen test to assess SARS-CoV-2 viability in de-isolation of patients with COVID-19

Catalog

Books, media, physical & digital resources